Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T20:56:30.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a generic error page; this change blocks access to the study's details and related sections.
    Difference
    16%
    Check dated 2026-09-19T20:11:21.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing v3.6.5, indicating a small maintenance update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:19.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now displays a new revision label, Revision: v3.6.5, replacing the previous Revision: v3.6.4, signaling a small update to the page's versioning. This change is a metadata update and does not affect the study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-08T18:21:36.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-25T10:20:55.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.2 to v3.6.3, indicating a small site update with no visible changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-03T22:36:12.000Z thumbnail image

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.